Modified vaccinia virus Ankara (MVA), having acquired genomic deletions during passage in chicken embryo fibroblasts, is highly attenuated and unable to productively infect most mammalian cell lines. (3, 14) . Neither the functions of the viral host range genes nor the precise stages at which replication is blocked by their loss or inactivation have been determined. Transformed cell lines that express poxvirus genes might provide new approaches to study virus-host interactions. Indeed, cell lines expressing adenovirus and herpesvirus genes have proven to be powerful tools for studying the replication of those viruses (7, 12, 24 
Vaccinia virus, the prototype Orthopoxvirus, can replicate in a wide range of cells. At least three viral genes, the vaccinia virus KlL and C7L and the cowpox 77-kDa genes, affect the host range of orthopoxviruses in tissue culture (9, 21, 25) . The desire to develop attenuated poxvirus expression vectors has stimulated efforts to determine the roles of host range genes in virulence (5, 28) . Both the KlL and 77-kDa genes encode proteins that contain ankyrin-like repeats, common to such diverse eukaryotic proteins as transcription factors, membrane receptors, and cell cycle regulators (3, 14) . Neither the functions of the viral host range genes nor the precise stages at which replication is blocked by their loss or inactivation have been determined. Transformed cell lines that express poxvirus genes might provide new approaches to study virus-host interactions. Indeed, cell lines expressing adenovirus and herpesvirus genes have proven to be powerful tools for studying the replication of those viruses (7, 12, 24) . Complementing cell lines that express poxvirus genes have not been described, perhaps because of the incompatibilities between the poxvirus and cellular transcription systems and the rapid inhibition of host gene expression following infection (18, 19) .
We decided to develop a complementing cell line to investigate host range defects in the highly attenuated modified vaccinia virus Ankara (MVA) strain. During serial passage in primary chicken embryo fibroblasts (CEF), the virus became highly attenuated and restricted for most mammalian cells (15) . MVA has six major genomic deletions affecting at least two host range genes (1, 16, 26) . Marker rescue of the partially deleted KlL host range gene with wild-type DNA enabled recombinant MVA to grow in the rabbit kidney cell line RK13 but not in other mammalian cells tested (16) . In (16) . The viruses were routinely propagated and titered in CEF grown in minimal essential medium (MEM) supplemented with 10% fetal calf serum (FCS) . The rabbit kidney cell line RK13 was also grown in MEM supplemented with 10% FCS. Virus multiplication was determined by infecting cell monolayers with 10 2 ,ug of pRc/CMV per 10-cm2 dish. G418-resistant colonies were selected as described above except that the medium contained 500 ,ig of G418 per ml and was replaced every third day. After 10 days, individual colonies were transferred to 24-well culture plates. Each clone was expanded to six-well and then to 75-cm2 dishes, at which time glycerol stocks were made in freezing medium (GIBCO/BRL). Screening was accomplished by seeding duplicate wells of 12-well plates with each cloned cell line and then infecting them at 30 PFU per cell with either vREICAT(KIL+) or vREKlL(KlL-) vaccinia virus. After 12 h, the cells were harvested and 3-galactosidase activity was measured as described below.
Analysis of cellular DNA. Total cellular DNA was isolated by standard procedures (23) and PCR amplified by using 35 cycles of 1 min at 94°C, 1 min at 55°C, and 2 min at 72°C. The primers used for amplification were GS49 (5'-GAC GAT ATC GAG ATC lFlll TGT ATA GGA GTC AGA-3') and GS54 (5'-CCA TTA CAT CAG GCA GCC ACA TTA GAA GAT ACC-3'). PCR products were analyzed by agarose gel electrophoresis. The same preparation of DNA was also digested with EcoRI and analyzed by electrophoresis on a 1% agarose gel. The DNA was transferred to a Hybond N+ membrane and hybridized with a 32P-labeled probe of 600 bp of vaccinia virus WT DNA from within the KlL ORF.
Reverse transcription-PCR analysis of RNA. Total RNA (3 jig) from infected cells was isolated as described by Chirgwin et al. (6) and transcribed with 25 U of avian myeloma virus reverse transcriptase (Boehringer Mannheim, Indianapolis, Ind.), using 0.5 jig of oligo(dT)1218 in a total volume of 50 jil at 42°C for 90 min in 50 mM Tris-HCl (pH 8.0)-70 mM KCl-10 mM MgCl2-1 mM each of the four deoxyribonucleoside triphosphates-4 mM dithiothreitol. Subsequently, the RNA was purified by phenol-chloroform extraction, precipitated with ethanol, and resuspended in 50 jil of H20. A 1-,ul portion was PCR amplified by using 40 cycles (as described above) with a DNA thermal cycler. PCR products were analyzed by agarose gel electrophoresis. The oligonucleotide primers used for the reaction were GS49 and GS54 (sequences are shown above).
Western immunoblotting. Proteins were resolved by electrophoresis on an SDS-11% polyacrylamide gel and electroblotted onto nitrocellulose for 2 h at 4°C in a buffer containing 25 mM Tris, 192 mM glycine, and 20% methanol (pH 8.6). The following procedures were done at room temperature. The blots were blocked in a phosphate-buffered saline (PBS) buffer containing 1% nonfat milk and 0.1% Nonidet P-40 (Sigma) for 1 h and then incubated for 3 h with antisera diluted 100-fold in the same PBS buffer. After being washed with 0.1% Nonidet (27) . After overnight incubation at 37°C, cytoplasmic extracts were prepared and the protein concentration (4) and ,B-galactosidase specific activity (17) were determined.
RESULTS
Macromolecular synthesis in MVA-infected RK13 cells. We had previously shown that viral early and late proteins were synthesized in human cells infected with MVA and that the block to replication occurred during virion assembly (27) . Similar analyses were performed by metabolically labeling RK13 cells with [35S]methionine for 30-min intervals at early and late times after infection. Autoradiograms of SDS-polyacrylamide gels containing proteins labeled at 2 h after infection with either WT or MVA-K1L, a recombinant MVA containing an intact KlL gene, revealed several prominent virus-induced early proteins of less than 40 kDa (Fig. 1A) . By 6 h, host protein synthesis was inhibited and prominent viral late proteins, including some greater than 60 kDa, were detected. By contrast, no protein synthesis was detected between 2 and 12 h after infection of RK13 cells with MVA (Fig.  1A) . To Fig. 2A) , although in the case of MVA-K1L, there was more of this RNA species at 1 h than at 4 h, and the reverse was true for MVA. The trend to delayed and prolonged early mRNA accumulation in cells infected with MVA, compared with MVA-K1L, was more obvious in the case of D9L (Fig. 2B) . The RNA bands of high molecular weight detected at 4 h after infection with MVAKlL are probably read-through products of the D1OL gene, which is expressed after DNA replication (Fig. 2B) . We note that both early mRNAs examined were present in MVAinfected cells at times well beyond the shutoff of protein synthesis (Fig. 1) .
When the blots were probed with the viral intermediate G8R gene, transcripts were detected in RK13 cells at 2 and 4 h after infection with MVA-K1L but not after infection with MVA (Fig. 2C) was dependent on transfection with the KlL expression plasmid (Fig. 4B) cate wells were seeded with each cell line and then infected with a high multiplicity of K1L-or a K1L+ recombinant vaccinia virus (strain WR) that contained lacZ regulated by the late 11K promoter, was devised. Although this screen had some background, ,-galactosidase activity induced by the K1L-virus did not approach that of the K1L+ virus in either the untransfected cell lines or the cell lines that had been transfected with pRc/CMV alone. By contrast, one of the cotransfected cell lines had as much ,B-galactosidase after infection with the K1L-virus as after infection with the K1L+ virus, and a few had intermediate levels.
Slot blot DNA-RNA hybridizations were carried out to determine whether there was a correlation between complementation of K1L-virus in the screening procedure and expression of the KlL gene. RNA was isolated from a total of 24 representative cell lines, including 3 nonrecombinant RK13 cell lines, 9 from the control pRc/CMV transfection group, 9 from the second doubly transfected group, and 2 that permitted strong MVA cytopathic effects in the first screen. Reactivity with the KlL probe was detected only with RNA samples from three cell lines: the two noted above from the first screen and the strongly positive one from the second screen. No attempts were made to further analyze cell lines that appeared weakly permissive during screening.
Further characterization of a stably transfected RK13 cell line. One of the permissive cell lines was chosen for further study. Integration of the viral KlL gene was demonstrated by PCR. Primers were designed to amplify a DNA fragment of 587 bp from within the vaccinia virus KlL ORF. Using DNA from RK13-K1L, we amplified a DNA fragment of the same size (Fig. SA) . This fragment comigrated with a PCR product that was amplified by using DNA derived from WT-infected HeLa cells. In contrast, PCR of DNA extracted from RK13 cells yielded no amplification product. When DNA isolated from RK13-KlL cells was digested with the restriction enzyme EcoRI, a single DNA fragment (2.8 kbp) that hybridized with a 32P-labeled KlL probe was detected (data not shown). This finding suggested that integration of the viral KlL gene occurred at a single site in the cell genome.
Reverse transcription-PCR analysis was used to confirm the presence of KlL RNA in the RK13-KlL cell line (Fig. SB) . First-strand products derived from purified RNA of WTinfected HeLa cells and uninfected RK13-KlL cells were amplified with the primers GS49 and GS54 to give PCR products of the expected sizes. The specificity of the PCR was confirmed with RNA from untransformed RK13 cells.
Synthesis of the KlL polypeptide by RK13-KlL cells was established by Western blotting using the anti-KlL peptide antiserum (10) (Fig. SC) . The antipeptide serum reacted specifically with a 32-kDa protein from MVA-KlL-infected CEF and uninfected RK13-KlL cells (marked by an arrowhead) corresponding in size to the KlL gene product.
Late gene expression in MVA-infected RK13-K1L cells. Two stably transfected RK13 cell lines were infected with MVA and incubated with [35S]methionine to determine whether the cells would support late gene expression. As negative controls, an untransfected RK13 cell line and one stably transfected with the neo gene alone were infected with MVA. As a positive control, RK13 cells were infected with the recombinant MVA-K1L. In each case, the labeled polypeptides were separated by SDS-PAGE and detected by autoradiography. Late viral proteins were made in MVA-infected RK13-KlL cells (Fig. 6A,  lanes 1 and 2) but not in the control RK13 cells (Fig. 6A, lanes  3 and 4) .
To ,B-galactosidase (27) . The recombinant protein, as well as late viral proteins, were absent in RK13 cells infected with MVA LZ (Fig. 6B) . These results were confirmed in a more quantitative manner by 1-galactosidase assays of extracts of MVA LZ-infected RK13-KlL cells (Fig. 6C) (27) and C7L sequences can be detected by DNA hybridization (26) .
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